Alpha‐Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body Synucleinopathies

Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophy

(2020) Mohammad Shahnawaz et al.   NATURE

Neurofilament Light Chain as a Biomarker in Multiple Sclerosis

(2019) Kristin N. Varhaug et al.   Frontiers in Neurology

Intrathecal administration of autologous mesenchymal stem cells in multiple system atrophy

(2019) Wolfgang Singer et al.   NEUROLOGY

Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial

(2019) Johannes Levin et al.   LANCET NEUROLOGY

Neurofilament Light Chain in Cerebrospinal Fluid and Blood as a Biomarker for Neurodegenerative Diseases: A Systematic Review and Meta-Analysis

(2019) Shao-Yang Wang et al.   JOURNAL OF ALZHEIMERS DISEASE

Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases

(2018) Claudio Soto et al.   NATURE NEUROSCIENCE

Prolonged Cerebrospinal Fluid Neurofilament Light Chain Increase in Patients with Post-Traumatic Disorders of Consciousness

(2017) Sergio Bagnato et al.   JOURNAL OF NEUROTRAUMA

Diagnosis and management of dementia with Lewy bodies

(2017) Ian G. McKeith et al.   NEUROLOGY

Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid

(2017) Mohammad Shahnawaz et al.   JAMA Neurology

Differentiation of neurodegenerative parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classification

(2016) Hans-Jürgen Huppertz et al.   MOVEMENT DISORDERS

Optimizing clinical trial design for multiple system atrophy: lessons from the rifampicin study

(2015) Wolfgang Singer et al.   CLINICAL AUTONOMIC RESEARCH

Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled trial

(2015) Werner Poewe et al.   LANCET NEUROLOGY

Natural history of multiple system atrophy in the USA: a prospective cohort study

(2015) Phillip A Low et al.   LANCET NEUROLOGY

When DLB, PD, and PSP masquerade as MSA

(2015) Shunsuke Koga et al.   NEUROLOGY

Propagation of prions causing synucleinopathies in cultured cells

(2015) Amanda L. Woerman et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism

(2015) Stanley B. Prusiner et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Novel therapeutic approaches in multiple system atrophy

(2014) Jose-Alberto Palma et al.   CLINICAL AUTONOMIC RESEARCH

Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial

(2014) Phillip A Low et al.   LANCET NEUROLOGY

Multiple system atrophy: Prognostic indicators of survival

(2014) Juan J. Figueroa et al.   MOVEMENT DISORDERS

Diffusion Tensor Imaging of Parkinson’s Disease, Multiple System Atrophy and Progressive Supranuclear Palsy: A Tract-Based Spatial Statistics Study

(2014) Amanda Worker et al.   PLoS One

The natural history of multiple system atrophy: a prospective European cohort study

(2013) Gregor K Wenning et al.   LANCET NEUROLOGY

The current and projected economic burden of Parkinson's disease in the United States

(2013) Stacey L. Kowal et al.   MOVEMENT DISORDERS

Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders

(2012) Sara Hall et al.   ARCHIVES OF NEUROLOGY

Phosphorylated α-synuclein as a potential biomarker for Parkinson’s disease and related disorders

(2012) Penelope Foulds et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests

(2012) Valeria Iodice et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Contribution of routine brain MRI to the differential diagnosis of parkinsonism: a 3-year prospective follow-up study

(2011) Frederick J. A. Meijer et al.   JOURNAL OF NEUROLOGY

Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression

(2010) Min Shi et al.   ANNALS OF NEUROLOGY

Detection of elevated levels of  -synuclein oligomers in CSF from patients with Parkinson disease

(2010) T. Tokuda et al.   NEUROLOGY

Prospective Differentiation of Multiple System Atrophy From Parkinson Disease, With and Without Autonomic Failure

(2009) Axel Lipp et al.   ARCHIVES OF NEUROLOGY

CHIP Targets Toxic α-Synuclein Oligomers for Degradation

(2008) Julie E. Tetzlaff et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Second consensus statement on the diagnosis of multiple system atrophy

(2008) S. Gilman et al.   NEUROLOGY

Formation of Toxic Oligomeric α-Synuclein Species in Living Cells

(2008) Tiago Fleming Outeiro et al.   PLoS One